Burling Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.04M Sell
13,688
-1,994
-13% -$592K 0.65% 44
2025
Q4
$4.28M Sell
15,682
-1,054
-6% -$286K 0.67% 39
2025
Q3
$4.52M Sell
16,736
-3,606
-18% -$981K 0.75% 36
2025
Q2
$5.61M Sell
20,342
-1,964
-9% -$534K 1.04% 26
2025
Q1
$5.92M Sell
22,306
-2,810
-11% -$693K 1.25% 20
2024
Q4
$5.83M Buy
+25,116
New +$5.78M 1.19% 24

Other funds holding CME

Burling Wealth Partners's CME Position: Q1 2026 in Review

Burling Wealth Partners reduced its CME Group (CME) stake by 13% in Q1 2026, selling an estimated $592K and leaving 13,688 shares worth $4.04M. The position accounts for 0.65% of the portfolio, ranked #44.

Burling Wealth Partners first reported a position in CME in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.92M in Q1 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Burling Wealth Partners held 13,688 shares of CME Group worth $4.04M as of Q1 2026.
  • Burling Wealth Partners sold 1,994 CME Group shares in Q1 2026, an estimated $592K.
  • CME Group made up 0.65% of Burling Wealth Partners's portfolio in Q1 2026, its #44 holding.
  • Burling Wealth Partners first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • Burling Wealth Partners's CME Group position peaked at $5.92M in Q1 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Burling Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.